NasaClip
NasaClip, with a valuation of $12 million, is raising funds on Wefunder. The company has developed an innovative and FDA-registered solution for nosebleeds. NasaClip is a hands-free, mess-free device that uses perfectly placed pressure with sponges that deliver medications to stop bleeding quickly and cleanly. The company has been featured on CNBC, ABC Good Morning, and MSNBC and has customers including Doctors on Duty, Disney, Adventist Health, and the University of Maryland Medical System. Dr. Elizabeth Clayborne, Romil Patel, and Dr. Neal Sikka founded NasaClip in July 2015. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $500,000. The campaign proceeds will be used for B2B sales, marketing, operations, and general and administrative expenses.
Investment Overview
Raised: $163,319
Deal Terms
Total Commitments ($USD)
- Platform
- Wefunder
- Start Date
- 10/22/2024
- Close Date
- 04/30/2025
$50,000
$500,000
$100
Equity - Preferred
Seed
RegCF
$1.08
$12,000,000
Company & Team
Company
- Year Founded
- 2015
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- High
- Capital Intensity
- Low
Financials
-
Revenue
- $28,518
- Monthly Burn
- $109,900
-
Runway
- 5.3 months
- Gross Margin
- 62%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $3,706,867
- Grants
- $256,000
- VC Backed?
- Yes
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/30/2025 | Wefunder | $12,000,000 | $163,319 | Equity - Preferred | Active | RegCF |